Mimics and challenging presentations of DADA2
Clinical and Experimental Immunology · 21.01.2025 · 219 (1)
DOI: 10.1093/cei/uxaf017 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical and Experimental Immunology, online erschienen am 21.03.2025. Verfasst von Admir Öztürk und 2 weiteren Autor:innen. Beteiligte Einrichtung: Medicine, Cerrahpasa Medical Faculty, University of Istanbul-Cerrahpasa, Istanbul, Türkiye. Hauptthemen laut MEDLINE: Adenosine Deaminase, Intercellular Signaling Peptides and Proteins, Polyarteritis Nodosa, Severe Combined Immunodeficiency. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Deficiency of adenosine deaminase 2 (DADA2) has been a challenging diagnosis to make since it was first described in 2014. The disease represents a wide range of phenotypes. Therefore, it may present with various clinical patterns. Throughout the years, several difficult-to-diagnose cases of DADA2 were reported in the literature. Although several studies and reviews were published regarding different phenotypes and manifestations of DADA2, a review of challenging cases with diverse combinations of DADA2 manifestations was needed to integrate the knowledge from the literature into the clinical practice. Immunological, hematologic, autoinflammatory, and adult-onset polyarteritis-nodosa patterns were reported in the literature as cases challenging to diagnose. In this review, we aim to summarize the challenging case reports from the literature, provide an algorithmic approach for these kinds of presentations, and share our perspective and recommendations on the topic. Diagnosing DADA2 on time is a vital issue for preventing fatal and debilitating vascular events with anti-TNF-alpha therapy. Thus, early testing for DADA2 in suspected cases is recommended. Family history and genetic testing of the patient and the first-degree relatives are essential for accurate diagnosis. Thorough systemic examination and imaging might help detect clinically silent findings of vasculitis. Enzymatic activity of ADA2, when available, is also a key diagnostic tool that complements genetic testing and clinical evaluation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medicine, Cerrahpasa Medical Faculty, University of Istanbul-Cerrahpasa, Istanbul, Türkiye.
- Division of Rheumatology, Department of Internal Medicine, Cerrahpasa Medical Faculty, University of Istanbul-Cerrahpasa, Istanbul, Türkiye.
ORCID-Profile: Admir Öztürk, Lara Yagci, Serdal Ugurlu
Zitieren
APA
Öztürk, A., Yagci, L., & Ugurlu, S. (2025). Mimics and challenging presentations of DADA2. Clinical and Experimental Immunology, 219(1). https://doi.org/10.1093/cei/uxaf017
Vancouver
Öztürk A, Yagci L, Ugurlu S. Mimics and challenging presentations of DADA2. Clinical and Experimental Immunology. 2025;219(1). doi:10.1093/cei/uxaf017
BibTeX
@article{ztrk2025,
author = {Öztürk, Admir and Yagci, Lara and Ugurlu, Serdal},
title = {Mimics and challenging presentations of DADA2},
journal = {Clinical and Experimental Immunology},
year = {2025},
volume = {219},
number = {1},
doi = {10.1093/cei/uxaf017}
}
EUVIMED